Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data

There is an unmet need to develop effective and tolerable treatments for pediatric patients with malignant central nervous system tumors. This is especially essential for pediatric patients with aggressive brain tumors such as high-grade gliomas, which have a typical survival rate of under 2 years....

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Stewart, Margol, Ashley, Hwang, Eugene I., Tanaka, Kazuhiro, Suchorska, Bogdana, Crawford, John R., Kesari, Santosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443515/
https://www.ncbi.nlm.nih.gov/pubmed/36072789
http://dx.doi.org/10.3389/fonc.2022.958637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443515/
https://www.ncbi.nlm.nih.gov/pubmed/36072789
http://dx.doi.org/10.3389/fonc.2022.958637

Ejemplares similares